Literature DB >> 18684883

Statins inhibit human APC function: implications for the treatment of GVHD.

Alexander Shimabukuro-Vornhagen, Tanja Liebig, Michael von Bergwelt-Baildon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18684883     DOI： 10.1182/blood-2008-04-149609

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  15 in total

Review 1.  Prevention of graft-vs.-host disease.

Authors:  Andrew R Rezvani; Rainer F Storb
Journal:  Expert Opin Pharmacother       Date:  2012-07-07       Impact factor: 3.889

Review 2.  Current and emerging strategies for the prevention of graft-versus-host disease.

Authors:  Sung Won Choi; Pavan Reddy
Journal:  Nat Rev Clin Oncol       Date:  2014-06-24       Impact factor: 66.675

3.  The evolving role of statins in hematopoietic stem and progenitor cell transplantation.

Authors:  Mehdi Hamadani; Michael D Craig; Laura F Gibson; Scot C Remick
Journal:  Am J Blood Res       Date:  2011-06-01

4.  Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Authors:  Marcello Rotta; Barry E Storer; Rainer Storb; Paul J Martin; Mary E D Flowers; Miwa S Vernon; Amanda Peffer; David G Maloney; H Joachim Deeg; Brenda M Sandmaier; Frederick R Appelbaum; Marco Mielcarek
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-26       Impact factor: 5.742

Review 5.  Immune modulatory effects of statins.

Authors:  Robert Zeiser
Journal:  Immunology       Date:  2018-02-20       Impact factor: 7.397

6.  Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation.

Authors:  Marcello Rotta; Barry E Storer; Rainer F Storb; Paul J Martin; Shelly Heimfeld; Amanda Peffer; David G Maloney; H Joachim Deeg; Brenda M Sandmaier; Frederick R Appelbaum; Marco Mielcarek
Journal:  Blood       Date:  2009-12-04       Impact factor: 22.113

7.  Overcoming immunological barriers in regenerative medicine.

Authors:  Johannes L Zakrzewski; Marcel R M van den Brink; Jeffrey A Hubbell
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

8.  Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).

Authors:  Yvonne A Efebera; Susan Geyer; Leslie Andritsos; Sumithira Vasu; Samantha Jaglowski; Anissa Bingman; William Blum; Rebecca Klisovic; Craig C Hofmeister; Don M Benson; Sam Penza; Patrick Elder; Katie Cortright; Rhonda Kitzler; Kevin Coombes; Lynn O'Donnell; Beth Daneault; Hillary Bradbury; Jianying Zhang; Xilin Chen; Sabrina Garman; Parvathi Ranganathan; Xueyan Yu; Jessica Hofstetter; Jianhua Yu; Ramiro Garzon; Scott R Scrape; Gerard Lozanski; Steven M Devine
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-06       Impact factor: 5.742

9.  Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.

Authors:  Sean Allen; Yu-Gang Liu; Evan Scott
Journal:  Regen Eng Transl Med       Date:  2016-03-03

10.  Statins impair CD1d-mediated antigen presentation through the inhibition of prenylation.

Authors:  Masood A Khan; Richard M Gallo; Gourapura J Renukaradhya; Wenjun Du; Jacquelyn Gervay-Hague; Randy R Brutkiewicz
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.